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Serum bromide has been used in the past to measure extracellular fluid volume in infants. In this 
report, a modification and refinement of a previously described spectrophotometric assay suitable for 
determining bromide levels in blood is presented. The assay involves sample deproteinization with 
perchloric acid followed by spectrophotometric analysis of the complexes formed by the reaction 
between sodium bromide and gold chloride. Linear standard curves were obtained by diluting 1:2 
with pooled serum at the following bromide concentrations: 10, 20, 30 and 40 mg%. Intra- and 
interassay variation using this technique was extremely small (n = 6, correlation coefficient, 0.995, 
and n = 5, correlation coefficient, 0.988, respectively). For toxicological analysis, a linear standard 
curve was derived from sodium bromide standards at the following concentrations: 40, 60, 80, and 
100 mg%. The reproducibility and reliability of this assay have been excellent and the correlaton with 
neutron activation analysis was excellent. The assay is easily adapted for the analysis of large numbers 
of samples, is easy to perform, and requires only small sample volumes. 
INTRODUCTION 
Measurement of extracellular fluid vol- 
ume in infants is very helpful in the evalu- 
ation of various treatment programs such as 
total parental nutrition and the fluid resus- 
citation of shock states. In the adult, these 
studies are frequently performed using ra- 
dioactive isotopes. In infants, however, the 
use of radioactive isotopes is precluded. The 
nonradioactive isotope sodium bromide has 
been used in the past to measure extracellular 
fluid in infants [l-3]. However, several dif- 
ferent techniques have been reported for de- 
termining the bromide ion concentration in 
biological fluids. Direct spectroscopy [4], 
neutron activiation analysis [ 51, diffusion 
techniques 161, and ion selective electrodes 
[7] have been used. These various methods 
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have their own disadvantages. There are in- 
terferences in direct spectroscopy and ion 
selective methodology, diffusion techniques 
are not very accurate, and neutron activation 
analysis is cumbersome and expensive. 
Of the techniques available, direct spec- 
troscopy is the most appealing. Multiple sam- 
ples may be analyzed quickly and precisely 
with very small sample volumes. We have 
significantly modified a spectrophotometric 
assay for bromide, initially reported by Wolf 
and Eadie [8] and subsequently modified by 
Cassady [4], in order to increase its repro- 
ducibility and reliability. The assay reported 
is easy to perform, uses small sample vol- 
umes, and correlates well with neutron ac- 
tivation analysis. 
MATERIALS AND METHODS 
Mongrel puppies, weighing between 3.0 
and 5.0 kg, and fasted overnight were anes- 
thetized with 25 mg/kg of pentobarbitol in- 
travenously. Catheters were inserted into the 
femoral artery and vein. A 5% sodium bro- 
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FIG. 1. Bromide assay standard curve. 
mide (NaBr) solution in a dose of 4 ml/kg 
body weight was injected into the femoral 
vein and blood samples were collected from 
the femoral artery at the following time in- 
tervals: prior to injection of the NaBr and 
every 30 min after injection for a total of 3 
hr. The blood samples were centrifuged at 
2000 rpm for 15 min at 4°C and the serum 
removed. 
Sodium chloride was included in the assay 
system in order to control for a slight degree 
of cross-reactivity between chloride and bro- 
mide. One, 5, and 10% NaCl concentrations 
were assayed for bromide (n = 8) to deter- 
mine if NaCl cross-reacts significantly in this 
assay system. The following values were ob- 
tained: 0.233 f 0.87, 0.50 + 0.84, and 0.46 
+ 0.59 mg% (mean f SD). From these data, 
it was concluded that NaCl does not signif- 
icantly interfere with the bromide determi- 
nation and that inclusion of 1.0 cc of 0.6% 
NaCl in the assay system protects against 
chloride variation between samples. 
It was observed that serum samples re- 
spond differently than standards in the assay. 
Serum samples reach a peak absorbance 3 
min after the addition of the supernatant to 
the AuC&-NaCl solution. Following this 
peak, the samples continue to lose absor- 
bance over time (Fig. 2). The standards 
The assay is performed in the following 
way: 0.5 cc of a standard or unknown sample 
is deproteinized in 1.0 cc of ice cold per- 
chloric acid (0.6 M). Following centrifuga- 
tion at 2000 rpm at 4°C for 5 mitt, 1 cc of 
supernatant is transferred to a test tube con- 
taining 1.0 cc of 0.6% sodium chloride 
(NaCl) and 1.0 cc of 0.0375% gold chloride 
(AuC&). Absorbance is recorded with a spec- 
trophotometer at 350 nm wavelength exactly 
3 min after the addition of the supernatant 
to the NaCl-AuC& solution. The spectro- 
photometer is zeroed with distilled water. 
The standards used in the assay are 5, 10, 15, 
and 20 mg% NaBr made up with double-dis- 
tilled deionized water. The assay is linear up 
to a concentration of NaBr of 40 mg%. All 
curves were derived from linear regression 
analysis. time. 
FIG. 2. Change in bromide sample absorbance with 
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RESULTS 
A typical standard curve is shown in Fig. 
1. The correlation coefficient for this data is 
0.997 (n = 7). The results of the analysis of 
the pooled serum were quite reproducible 
with means + standard deviations of 0.166 
f 0.33 and 13.17 + 0.52 mg% (n = 10) for 
a typical low and high pooled serum con- 
centration. No significant differences were 
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which are made up with distilled water are 
stable and do not change absorbance over 
time. Therefore, standards of 10,20, 30, and 
40 mg% diluted 1:2 with pooled serum were 
prepared. These standard samples responded 
in the same manner as the unknown serum 
samples. Figure 3 shows the intraassay vari- 
ation using this technique (n = 6, correlation 
coefficient, 0.995). Interassay variation using 
these standard samples is depicted in Fig. 4 
(n = 5, correlation coefficient, 0.988). An ex- 
ample of a typical group of samples taken 
from an experimental animal and assayed 
using the described method and nuclear ac- 
tivation analysis is presented in Fig. 5. 
DISCUSSION 
This modification of the spectrophoto- 
metric assay for serum bromide differs from 
the method described by Cassady in several 
important aspects. First, deproteinization of 
the serum sample with perchloric acid rather 
than zinc hydroxide is important since in- 
complete protein precipitation often results 
in spurious data and poor reproducibility. By 
keeping the entire procedure in an acid en- 
vironment, the reliability of the assay system 
is greatly improved. Second, it is important 
to read the peak absorbance value at 3 min, 
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FIG. 3. Intraassay variation for bromide standard 
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FIG. 4. Interassay variation for bromide standard 
curve (diluted I:2 with pooled serum) (n = 5). 
rather than at 15 min, because significant 
decreases in absorbance occur over time. 
Lastly, it is necessary to use standards diluted 
1:2 with pooled serum in order to achieve 
the correct bromide value. Otherwise, the 
bromide concentration is falsely low. This 
was substantiated by comparison with neu- 
tron activation analysis. 
The attractiveness of this assay prompted 
us to evaluate its use at higher serum con- 
centrations of bromide such as occur with 
medication overdose. For toxicological anal- 
ysis, a linear relationship exists using stan- 
dards at the following NaBr concentrations: 
40,60,80, and 100 mg%. The only procedure 
modification required with this range of bro- 
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FIG. 5. Comparison of spectrophotometric bromide 
assay with neutron activation analysis. 
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0.0375% AuC& instead of 1 cc as was de- 
scribed previously. With these modifications, 
a linear curve is obtained with bromide con- 
centrations between 40 and 100 mg%, an 
appropriate range for toxicological assays. 
The reproducibility and reliability of this 
assay has been excellent and the correlation 
with neutron acitivation analysis has been 
very close. The assay is easily adapted for 
large numbers of samples by carefully stag- 
gering the addition of the supematant to the 
AuC&-NaCl solution at 15-set intervals and 
by analyzing the samples in blocks of 12 dur- 
ing each 3-min interval. 
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